Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SGLT-2 Inhibitor”

396 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 396 results

Not applicableStudy completedNCT07332156
What this trial is testing

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Who this might be right for
Type 2 DiabetesCOPD (Chronic Obstructive Pulmonary Disease)Lung Cancer (Diagnosis)
Samsung Medical Center 21,692
Not applicableNot Yet RecruitingNCT06739486
What this trial is testing

Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease

Who this might be right for
Non Alcholic Fatty Liver DiseaseHepatic SteatosisHepatic Fibrosis+1 more
Assiut University 100
Not applicableStudy completedNCT02857764
What this trial is testing

Sodium-glucose Co-transporter 2 (SGLT2) Inhibitor Risk of Below-Knee Lower Extremity Amputation: A Retrospective Cohort Study Using a Large Claims Database in the United States

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 127,690
Not applicableLooking for participantsNCT07601867
What this trial is testing

Effect of Dapagliflozin on Right Ventricular-Pulmonary Artery Coupling After Off-Pump Coronary Atery Bypass Grafting

Who this might be right for
Heart FailureCoronary Arterial Disease
Pyatigorsk City Clinical Hospital Number 1 72
Testing effectiveness (Phase 2)Study completedNCT04818034
What this trial is testing

The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary Study

Who this might be right for
Cystinuria
University of California, San Francisco 10
Not applicableNot Yet RecruitingNCT07708610
What this trial is testing

Preadmission GLP-1 Receptor Agonist Plus SGLT2 Inhibitor Use and Early Outcomes After Pneumonia Hospitalization in Adults With Type 2 Diabetes

Who this might be right for
PneumoniaType 2 Diabetes Mellitus (T2DM)
Chung Shan Medical University 71,775
Post-approval studies (Phase 4)Active Not RecruitingNCT07325435
What this trial is testing

Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists

Who this might be right for
Type 2 Diabetes (T2DM)
MaryAnn Banerji 60
Post-approval studies (Phase 4)Study completedNCT02914691
What this trial is testing

Effects of Dapagliflozin Treatment on Urinary Proteomic Patterns in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesDiabetic Nephropathy
Peter Rossing 40
Post-approval studies (Phase 4)UnknownNCT04340908
What this trial is testing

Effects of SGLT2 Inhibitor on Type 2 Diabetic Patients Undergoing Cardiac Surgery

Who this might be right for
Diabetes Mellitus, Type 2Cardiac Surgery
Hongchang Guo 500
Post-approval studies (Phase 4)Study completedNCT05309785
What this trial is testing

Safety and Efficacy of Canagliflozin in Advanced CKD

Who this might be right for
ESRDCKD Stage 4CKD Stage 5
McGill University Health Centre/Research Institute of the McGill University Health Centre 34
Large-scale testing (Phase 3)Study completedNCT02597049
What this trial is testing

Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Eli Lilly and Company 424
Testing effectiveness (Phase 2)UnknownNCT04419337
What this trial is testing

Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke

Who this might be right for
Diabetes MellitusStroke
Chang Gung Memorial Hospital 200
Not applicableStudy completedNCT06453577
What this trial is testing

Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
Universität des Saarlandes 33
Early research (Phase 1)Study completedNCT03560323
What this trial is testing

Ketones, Muscle Metabolism, and SGLT2 Inhibitors - Protocol 1

Who this might be right for
Heart FailureType 2 Diabetes Mellitus
The University of Texas Health Science Center at San Antonio 41
Large-scale testing (Phase 3)Study completedNCT01387737
What this trial is testing

Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Tanabe Pharma Corporation 1,299
Post-approval studies (Phase 4)Not Yet RecruitingNCT07108985
What this trial is testing

Effect of Add-on SGLT2i, TZD, or Combination Therapy in Type 2 Diabetes Patients on DPP4 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2HyperglycemiaInsulin Resistance
Yonsei University 100
Post-approval studies (Phase 4)UnknownNCT03398577
What this trial is testing

Effects of SGLT2 Inhibitor in Diabetic Patients With Coronary Artery Disease

Who this might be right for
Coronary Disease With Diabetes Mellitus
Sheba Medical Center 61
Testing effectiveness (Phase 2)Looking for participantsNCT06913647
What this trial is testing

Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis

Who this might be right for
ESRDCKD (Chronic Kidney Disease) Stage 5D
McGill University Health Centre/Research Institute of the McGill University Health Centre 30
Post-approval studies (Phase 4)Study completedNCT06374043
What this trial is testing

Decentralized N=1 Study: A Feasible Approach to Evaluate Individual Therapy Response to Dapagliflozin.

Who this might be right for
Diabetes Mellitus, Type 2Diabetes Mellitus Type 2 With ProteinuriaDiabetes Mellitus+7 more
University Medical Center Groningen 20
Not applicableNot Yet RecruitingNCT07392788
What this trial is testing

Early Gliflozin for Elderly Patients With Acute Decompensated Heart Failure in the Emergency Department

Who this might be right for
Acute Heart Failure (AHF)
Centre Hospitalier Universitaire de Besancon 144
Next Page